H.R. 8726

H.R. 8726: To amend title XVIII of the Social Security Act to allow States to enforce Medicare Advantage plan requirements.

Introduced Troy Downing (R) HOUSE_BILL — 119th Congress
Plain English Summary

H.R. 8726 is a bill that aims to amend the Social Security Act to give states the authority to enforce requirements related to Medicare Advantage plans. This means that states would have more power to ensure that these private insurance plans comply with certain standards and regulations, potentially enhancing consumer protections for Medicare beneficiaries.

Positive Media Summary

Supporters of H.R. 8726 argue that allowing states to enforce Medicare Advantage plan requirements could lead to better oversight and improved services for seniors. They believe that state-level enforcement could help hold insurance companies accountable and ensure that beneficiaries receive the benefits they are entitled to.

Negative Media Summary

Critics of H.R. 8726 express concerns that granting states the authority to enforce Medicare Advantage plan requirements could lead to inconsistencies in regulation across different states. They worry that this might create confusion for beneficiaries and could result in unequal protections depending on where a person lives.

Conflict of Interest Analysis Deep Analysis
3/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Health

The analysis of H.R. 8726, sponsored by Troy Downing, reveals no direct industry overlaps between the sponsor's top donor industries and the bill's subject matter, which pertains to Medicare Advantage plan requirements. While there is significant lobbying activity in the policy area, the disclosed amounts do not indicate a clear financial incentive tied to the bill. The only disclosed contribution is from DIRSHU INTERNATIONAL, which contributed $100,000, but there is no direct link between this organization and the specific provisions of the bill. Overall, the absence of overlapping donor industries and the lack of substantial financial ties suggest a low risk of conflicts of interest. Voters should be aware that while lobbying exists, it does not directly correlate to the sponsor's financial backers in this case.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
DIRSHU INTERNATIONAL MERKAVA STRATEGIES CORPORATION $100,000
CEO WORKS SAUNDERS GLOBAL DIPLOMACY $45,000
KAZI IG SAUNDERS GLOBAL DIPLOMACY $15,000
SOUTHERN FOLGER CONTRACTING BBT STRATEGIES LLC $10,000
WATERFRONT GLOBAL BBT STRATEGIES LLC $5,200
DIGITALEUROPE VIVID STRATEGIES LLC undisclosed
INTERNATIONAL CHRISTIAN CHAMBER OF COMMERCE MERKAVA STRATEGIES CORPORATION undisclosed
DR. STEPHEN SOLOWAY MERKAVA STRATEGIES CORPORATION undisclosed
ONE ISRAEL FUND MERKAVA STRATEGIES CORPORATION undisclosed
HEMOGLOBIN OXYGEN THERAPEUTICS MERKAVA STRATEGIES CORPORATION undisclosed
ATAOLLAH AMINPOUR MERKAVA STRATEGIES CORPORATION undisclosed
HERSEL NEMAN MERKAVA STRATEGIES CORPORATION undisclosed
MORAD BEN NEMAN MERKAVA STRATEGIES CORPORATION undisclosed
MARK SCOTT MERKAVA STRATEGIES CORPORATION undisclosed
BORIS MINTS MERKAVA STRATEGIES CORPORATION undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Troy Downing, ranked by total contributions.

Health Professionals $120,000,000
Individuals: $120,000,000 PACs: $0
Retired $37,500,000
Individuals: $37,500,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us